Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Robert Gronke, PhD
Senior Principal Scientist at Biogen, Inc
Speaker

Profile

Robert Gronke is a Senior Principal Scientist in the Antisense Oligonucleotide department at Biogen. For 36 years, he’s led the purification process development, CMC leadership, and new technology assessments for Biogen’s commercial ASO products Qalsody and Spinraza along with biological products AVONEX, PLEGRIDY, BENEPALI, plus more than 25 clinical products. Rob currently manages a group of 6 associate scientists.

Prior to joining Biogen, Inc., Dr. Gronke was a post-doctoral fellow in the Pharmacology Department at Merck. He holds a Ph.D. degree in Biochemistry from the University of Kansas, Lawrence Kansas and a BS degree in Biochemistry from Northern Illinois University.

Agenda Sessions

  • Chairperson’s Remarks: Track 1

    1:40pm
  • Understanding UF/DF Capabilities for Enhancing ASO Processing to Make a Liquid or Lyo API

    1:45pm